|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM172233070 |
| 003 |
DE-627 |
| 005 |
20231223131347.0 |
| 007 |
tu |
| 008 |
231223s2007 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0574.xml
|
| 035 |
|
|
|a (DE-627)NLM172233070
|
| 035 |
|
|
|a (NLM)17710758
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Will drugs someday reverse CAD? Three recent advances bring the possibility closer to reality
|
| 264 |
|
1 |
|c 2007
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 22.08.2007
|
| 500 |
|
|
|a Date Revised 21.10.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Apolipoprotein A-I
|2 NLM
|
| 650 |
|
7 |
|a Fluorobenzenes
|2 NLM
|
| 650 |
|
7 |
|a Hypolipidemic Agents
|2 NLM
|
| 650 |
|
7 |
|a Pyrimidines
|2 NLM
|
| 650 |
|
7 |
|a Sulfonamides
|2 NLM
|
| 650 |
|
7 |
|a Rosuvastatin Calcium
|2 NLM
|
| 650 |
|
7 |
|a 83MVU38M7Q
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Heart advisor
|d 1999
|g 10(2007), 5 vom: 26. Mai, Seite 1, 7
|w (DE-627)NLM098274252
|x 1523-9004
|7 nnns
|
| 773 |
1 |
8 |
|g volume:10
|g year:2007
|g number:5
|g day:26
|g month:05
|g pages:1, 7
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 10
|j 2007
|e 5
|b 26
|c 05
|h 1, 7
|